{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:20:07Z","timestamp":1780078807797,"version":"3.54.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,20]]},"DOI":"10.7759\/cureus.17332","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T17:26:58Z","timestamp":1629480418000},"source":"Crossref","is-referenced-by-count":16,"title":["A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?"],"prefix":"10.7759","author":[{"given":"Hajra","family":"Khurshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa A","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry R","family":"Went","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-020-00024-2","article-title":"Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019)","volume":"2","author":"Cameron EC","year":"2020","unstructured":"Cameron EC, Hemingway SL. Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019). J Cannabis Res. 2020, 2:19. 10.1186\/s42238-020-00024-2","journal-title":"J Cannabis Res"},{"key":"ref2","article-title":"The Second International Congress on Controversies in Fibromyalgia","volume":"38","author":"Ablin JN","year":"2020","unstructured":"Ablin JN, Sarzi-Puttini P. The Second International Congress on Controversies in Fibromyalgia. Clin Exp Rheumatology. 2020, 38:105-30.","journal-title":"Clin Exp Rheumatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041186","article-title":"T cell subpopulations in the physiopathology of fibromyalgia: evidence and perspectives","volume":"21","author":"Banfi G","year":"2020","unstructured":"Banfi G, Diani M, Pigatto PD, Reali E. T cell subpopulations in the physiopathology of fibromyalgia: evidence and perspectives. Int J Mol Sci. 2020, 21:1186. 10.3390\/ijms21041186","journal-title":"Int J Mol Sci"},{"key":"ref4","article-title":"One year in review 2020: fibromyalgia","volume":"38","author":"Bazzichi L","year":"2020","unstructured":"Bazzichi L, Giacomelli C, Consensi A, Giorgi V, Batticciotto A, Di Franco M, Sarzi-Puttini P. One year in review 2020: fibromyalgia. Clin Exp Rheumatology. 2020, 38:3-8.","journal-title":"Clin Exp Rheumatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00561","article-title":"A balanced approach for cannabidiol use in chronic pain","volume":"11","author":"Argueta DA","year":"2020","unstructured":"Argueta DA, Ventura CM, Kiven S, Sagi V, Gupta K. A balanced approach for cannabidiol use in chronic pain. Front Pharmacol. 2020, 11:561. 10.3389\/fphar.2020.00561","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie N","year":"2017","unstructured":"Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease. Eur J Rheumatol. 2017, 4:210-8. 10.5152\/eurjrheum.2017.17025","journal-title":"Eur J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10436","article-title":"Cannabinoid receptors and their relationship with chronic pain: a narrative review","volume":"12","author":"Anthony AT","year":"2020","unstructured":"Anthony AT, Rahmat S, Sangle P, Sandhu O, Khan S. Cannabinoid receptors and their relationship with chronic pain: a narrative review. Cureus. 2020, 12:e10436. 10.7759\/cureus.10436","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217877","article-title":"Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies","volume":"21","author":"Maffei ME","year":"2020","unstructured":"Maffei ME. Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies. Int J Mol Sci. 2020, 21:7877. 10.3390\/ijms21217877","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/rxk6s4","article-title":"Physical and mental impact of COVID-19 outbreak on fibromyalgia patients","volume":"39","author":"Aloush V","year":"2021","unstructured":"Aloush V, Gurfinkel A, Shachar N, Ablin JN, Elkana O. Physical and mental impact of COVID-19 outbreak on fibromyalgia patients. Clin Exp Rheumatol. 2021, 39:108-14.","journal-title":"Clin Exp Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6541798","article-title":"Current and emerging pharmacotherapy for fibromyalgia","volume":"2020","author":"Tzadok R","year":"2020","unstructured":"Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020, 2020:6541798. 10.1155\/2020\/6541798","journal-title":"Pain Res Manag"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10389","article-title":"Cannabis and cannabinoids in the treatment of rheumatic diseases","volume":"11","author":"Gonen T","year":"2020","unstructured":"Gonen T, Amital H. Cannabis and cannabinoids in the treatment of rheumatic diseases. Rambam Maimonides Med J. 2020, 11:e0007. 10.5041\/RMMJ.10389","journal-title":"Rambam Maimonides Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5497\/wjp.v6.i1.1","article-title":"Emerging pharmacological strategies for the treatment of fibromyalgia","volume":"6","author":"Lawson K","year":"2017","unstructured":"Lawson K. Emerging pharmacological strategies for the treatment of fibromyalgia. World J Pharmacol. 2017, 6:1-10. 10.5497\/wjp.v6.i1.1","journal-title":"World J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa163","article-title":"Medical cannabis for the management of pain and quality of life in chronic pain patients: a prospective observational study","volume":"21","author":"Safakish R","year":"2020","unstructured":"Safakish R, Ko G, Salimpour V, Hendin B, Sohanpal I, Loheswaran G, Yoon SY. Medical cannabis for the management of pain and quality of life in chronic pain patients: a prospective observational study. Pain Med. 2020, 21:3073-86. 10.1093\/pm\/pnaa163","journal-title":"Pain Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011694.pub2","article-title":"Cannabinoids for fibromyalgia","volume":"7","author":"Walitt B","year":"2016","unstructured":"Walitt B, Klose P, Fitzcharles MA, Phillips T, H\u00e4user W. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016, 7:CD011694. 10.1002\/14651858.CD011694.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","article-title":"Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines","author":"Banerjee S","year":"2019","unstructured":"Banerjee S, McCormack S. Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines. Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada; 2019."},{"key":"ref17","article-title":"","author":"Birks A","year":"2021","unstructured":"Birks A, Goodburn J, Loutsch D. The Effects of Cannabinoids on Individuals with Chronic Pain: A Critically Appraised Topic. NWCommons, Orange City, Iowa; 2021. https:\/\/nwcommons.nwciowa.edu\/celebrationofresearch\/2021\/researchprojects2021\/27\/."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8857948","article-title":"Medical cannabis for chronic noncancer pain: a systematic review of health care Recommendations","volume":"2021","author":"Chang Y","year":"2021","unstructured":"Chang Y, Zhu M, Vannabouathong C, Mundi R, Chou RS, Bhandari M. Medical cannabis for chronic noncancer pain: a systematic review of health care Recommendations. Pain Res Manag. 2021, 2021:8857948. 10.1155\/2021\/8857948","journal-title":"Pain Res Manag"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk T","year":"2019","unstructured":"van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019, 160:860-9. 10.1097\/j.pain.0000000000001464","journal-title":"Pain"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21767\/2471-982X.100016","article-title":"Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study","volume":"37","author":"Yassin M","year":"2019","unstructured":"Yassin M, Oron A, Robinson D. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. Clin Exp Rheumatol. 2019, 37:13-20. 10.21767\/2471-982X.100016","journal-title":"Clin Exp Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060807","article-title":"Safety and efficacy of medical cannabis in fibromyalgia","volume":"8","author":"Sagy I","year":"2019","unstructured":"Sagy I, Bar-Lev Schleider L, Abu-Shakra M, Novack V. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019, 8:807. 10.3390\/jcm8060807","journal-title":"J Clin Med"},{"key":"ref22","article-title":"Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study","volume":"38","author":"Giorgi V","year":"2020","unstructured":"Giorgi V, Bongiovanni S, Atzeni F, Marotto D, Salaffi F, Sarzi-Puttini P. Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. Clin Exp Rheumatol. 2020, 38:53-9.","journal-title":"Clin Exp Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa303","article-title":"Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a\u00a0randomized, double-blind, placebo-controlled clinical trial","volume":"21","author":"Chaves C","year":"2020","unstructured":"Chaves C, Bittencourt PC, Pelegrini A. Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a\u00a0randomized, double-blind, placebo-controlled clinical trial. Pain Med. 2020, 21:2212-8. 10.1093\/pm\/pnaa303","journal-title":"Pain Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series","volume":"3","author":"Mazza M","year":"2021","unstructured":"Mazza M. Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series. J Cannabis Res. 2021, 3:4. 10.1186\/s42238-021-00060-6","journal-title":"J Cannabis Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65839-a-systematic-review-of-fibromyalgia-and-recent-advancements-in-treatment-is-medicinal-cannabis-a-new-hope","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:22Z","timestamp":1707507022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65839-a-systematic-review-of-fibromyalgia-and-recent-advancements-in-treatment-is-medicinal-cannabis-a-new-hope"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.17332","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}